Search

Your search keyword '"DIEZ-FAIREN, M."' showing total 114 results

Search Constraints

Start Over You searched for: Author "DIEZ-FAIREN, M." Remove constraint Author: "DIEZ-FAIREN, M."
114 results on '"DIEZ-FAIREN, M."'

Search Results

1. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

2. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort

3. Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers

4. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)

5. New insights into the genetic etiology of Alzheimer's disease and related dementias

6. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

7. Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson's Disease

8. Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study

9. Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers

10. Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson's Disease

11. Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study

12. Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson's Disease

13. New insights into the genetic etiology of Alzheimer's disease and related dementias

14. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

15. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

16. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

17. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

18. Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage

19. Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease

20. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

21. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

22. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

23. Correction to: Large‑scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease

24. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019)

25. Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information

26. Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset

27. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson's disease heritability

28. SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease

29. The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE ¿4 Non-carriers

30. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

31. High ultrasensitive serum C-reactive protein may be related to freezing of gait in Parkinson's disease patients

32. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation

33. The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE epsilon 4 Non-carriers

34. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A beta, tau, immunity and lipid processing (vol 51, pg 414, 2019)

35. Nat Genet

36. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)

37. Polygenic risk and hazard scores for Alzheimer's disease prediction

38. SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease

39. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing

40. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort

41. Moving beyond neurons:the role of cell type-specific gene regulation in Parkinson’s disease heritability

42. Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease.

43. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

44. Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s Disease

45. Association of Body Mass Index and Parkinson Disease: A Bidirectional Mendelian Randomization Study.

46. Genome sequence analyses identify novel risk loci for multiple system atrophy.

47. A genetic and transcriptomic assessment of the KTN1 gene in Parkinson's disease risk.

48. An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response.

49. Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers.

50. Mendelian Randomisation Confirms the Role of Y-Chromosome Loss in Alzheimer's Disease Aetiopathogenesis in Men.

Catalog

Books, media, physical & digital resources